000 01455 a2200397 4500
005 20250518050507.0
264 0 _c20210924
008 202109s 0 0 eng d
022 _a1477-0970
024 7 _a10.1177/1352458519860327
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhorooshi, Reza
245 0 0 _aAngiotensin AT2 receptor-induced interleukin-10 attenuates neuromyelitis optica spectrum disorder-like pathology.
_h[electronic resource]
260 _bMultiple sclerosis (Houndmills, Basingstoke, England)
_c09 2020
300 _a1187-1196 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAquaporin 4
_xgenetics
650 0 4 _aAutoantibodies
650 0 4 _aHumans
650 0 4 _aInterleukin-10
650 0 4 _aMice
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aNeuromyelitis Optica
_xdrug therapy
650 0 4 _aReceptor, Angiotensin, Type 2
700 1 _aTofte-Hansen, Emil Ulrikkaholm
700 1 _aTygesen, Camilla
700 1 _aMontanana-Rosell, Roser
700 1 _aLimburg, Hannah Liska
700 1 _aMarczynska, Joanna
700 1 _aAsgari, Nasrin
700 1 _aSteckelings, Ulrike Muscha
700 1 _aOwens, Trevor
773 0 _tMultiple sclerosis (Houndmills, Basingstoke, England)
_gvol. 26
_gno. 10
_gp. 1187-1196
856 4 0 _uhttps://doi.org/10.1177/1352458519860327
_zAvailable from publisher's website
999 _c29883282
_d29883282